Is this you? Create Your Porfile
Avatar

Reinhard Kirsch

Aventis Pharma

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Reinhard Kirsch is active.

Explore More

Publication

Featured researches published by Reinhard Kirsch.

Chemistry & Biology | 2005

Structural Basis for the Highly Selective Inhibition of MMP-13

Christian Engel; Bernard Pirard; Sandra Schimanski; Reinhard Kirsch; Jörg Habermann; Otmar Klingler; Volkhard Schlotte; Klaus Ulrich Weithmann; K. Ulrich Wendt

Archive | 1999

Aryl-substituted propanolamine derivatives, their preparation, pharmaceuticals comprising them, and their use

Wendelin Frick; Reinhard Kirsch; Heiner Glombik; Werner Kramer; Hans-Ludwig Schäfer

Archive | 2000

Sulfonylcarboxamide derivatives, process for their preparation and their use as pharmaceuticals

Reinhard Kirsch; Hans-Ludwig Schaefer; Eugen Falk; Horst Hemmerle

Virology | 1994

Mutational analysis of residue 190 of human immunodeficiency virus type 1 reverse transcriptase.

Jörg-Peter Kleim; Rudolf Dr Bender; Reinhard Kirsch; Christoph Meichsner; Arno Paessens; Günther Rieb

Virology | 1997

In VitroSelection for Different Mutational Patterns in the HIV-1 Reverse Transcriptase Using High and Low Selective Pressure of the Nonnucleoside Reverse Transcriptase Inhibitor HBY 097

Jörg-Peter Kleim; Irvin Winkler; Manfred Rosner; Reinhard Kirsch; Helga Rübsamen-Waigmann; Arno Paessens; Gunther Riess

Archive | 1995

Quinoxalines, process for their preparation, and their use

Manfred Rosner; Uta-Maria Billhardt-Troughton; Reinhard Kirsch; Jörg-Peter Kleim; Christoph Meichsner; Gunther Riess; Irvin Winkler

Archive | 2002

PYRIDINE-2,4-DICARBOXYLIC ACID DIAMIDES AND PYRIMIDINE-4,6-DICARBOXYLIC ACID DIAMIDES AND THE USE THEREOF FOR SELECTIVELY INHIBITING COLLAGENASES

Klaus-Ulrich Weithmann; Jörg Habermann; Herbert Kogler; Reinhard Kirsch; Volkmar Wehner

Archive | 1983

Substituted phenylsulfonyloxybenzimidazolecarbamates and anthelmintic compositions

Manfred Rosner; Heinz Loewe; Dieter Duwel; Reinhard Kirsch

Archive | 1999

Substituted 1,3-diaryl-2-pyridine-2-yl-3-(pyridine-2-ylamino)-propanol derivatives, methods for their production, pharmaceutical compositions containing the same and their use

Reinhard Kirsch; Alfons Enhsen; Heiner Glombik; Werner Kramer; Eugen Falk

Archive | 2002

Use of pyridine-2,4-dicarboxylic acid diamides and of pyrimidine-4,6-dicarboxylic acid diamides for selective collagenase inhibition

Klaus-Ulrich Weithmann; Jörg Habermann; Herbert Kogler; Reinhard Kirsch; Volkmar Wehner

Explore More

Collaboration

Dive into the Reinhard Kirsch's collaboration.

Top Co-Authors
Avatar

Heiner Glombik

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Werner Kramer

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Manfred Rosner

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Wendelin Frick

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Eugen Falk

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Hans-Ludwig Schaefer

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Irvin Winkler

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Klaus-Ulrich Weithmann

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Volkmar Wehner

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Gunther Riess

Aventis Pharma

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge